Concepedia
Statistics
Publications
22
Citations
2.2K
H-Index
21
Active since
1991
Affiliations
Bristol-Myers Squibb (United States)(Current)
Pharmaceutical Product Development (United States)
Purdue University West Lafayette
Gimbel Eye Centre
Protein Express (United States)
Michael Furlong is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and drug analysis.
Top concepts
MedicinePharmacologyDrug AnalysisChemistryBiochemistryCell BiologyChromatographyNatural SciencesClinical ChemistrySurgery
Publications per year
1991–2015
Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk
Martin Turner, P. Joseph Mee, Patrick Costello et al. · Nature · 1995 · 721 citations
Developmental Biology, Signaling Pathway, Cell Regulation +12
Incidence and management of intraoperative and early postoperative complications in 1000 consecutive laser in situ keratomileusis cases
Howard V. Gimbel, Ellen E. Anderson Penno, John A van Westenbrugge et al. · Ophthalmology · 1998 · 298 citations
Keratoconus, Consecutive Laser, Ophthalmology +7
Syk, Activated by Cross-linking the B-cell Antigen Receptor, Localizes to the Cytosol Where It Interacts with and Phosphorylates α-Tubulin on Tyrosine
Jennifer D. Peters, Michael Furlong, David J. Asai et al. · Journal of Biological Chemistry · 1996 · 143 citations · Full text
Identification of the major sites of autophosphorylation of the murine protein-tyrosine kinase Syk
Michael Furlong, Alan M. Mahrenholz, Ki-Han Kim et al. · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 1997 · 123 citations
Signal Transduction, Signaling Pathway, Biochemistry +9
Preparation and reactivity of chiral β-amido-alkylzinc iodides and related configurationally stable zinc organometallics
Rajagopal Duddu, Matthias Eckhardt, Michael Furlong et al. · Tetrahedron · 1994 · 102 citations
Chemical Engineering, Chiral β-Amido-alkylzinc Iodides, Organometallic Catalysis +3
1–5 of 22